Should People be Allowed To Sell Their Organs?
By Alice Park,
Time / CNN
| 07. 03. 2012
How much would it take for you to consider selling your bone marrow? A
U.S. appeals court puts the price at about $3,000 in a ruling that now
makes it legal to pay donors for their bone-marrow tissue.
The court's decision may
well help thousands of sick patients who need bone-marrow transplants to
survive, but it also begs the question, What other body parts might
next be up for sale?
The ruling
came about at the end of 2011, in a decision to an October 2009 lawsuit
brought by a group of cancer patients, parents and bone-marrow-donation
advocates against the government over the federal law banning the
buying and selling of bodily organs. The plaintiffs were led by Doreen
Flynn, who has three daughters who suffer from Fanconi anemia, a blood disorder that requires bone-marrow transplants to treat.
Flynn and the other
plaintiffs said that too many such patients die waiting for transplants
and argued that we should be allowed to pay people to donate their
marrow as a way of ensuring a more reliable supply. The U.S. Court...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
